CleveMed Blogs

CleveMed specializes in the manufacture of wireless, subject-worn physiological monitoring equipment. Within the Division of Research and Education systems, a number of wireless data acquisition devices are offered for a variety of applications.

BioCapture is a research system that uses the BioRadio, a wireless data acquisition device for physiological monitoring. The BioRadio can measure any combination of signals such as ECG, EMG, EEG, EOG, respiration, SpO2 and more. Data is telemetered to a receiver connected to a nearby PC. The information is displayed through the software and data can be exported for analysis in third party applications, such as LabView, Matlab or Excel. The BioCapture system is suitable for a number biomedical research applications.

CleveLabs is a laboratory course system that uses the same data acquisition device as BioCapture, the BioRadio. The software is different, in that it is tailored toward students as a laboratory teaching system focusing on engineering, physiology and clinical applications. Biomedical engineering, physiology, electrical & computer engineering and other departments can benefit from this technology. The system is very flexible and can be used in biomedical engineering labs and classrooms, biomedical research applications, physiology labs and research, and more.

KinetiSense is a wireless data acquisition system that measures three dimensional motion using accelerometers and gyroscopes. Linear acceleration and angular velocity are measured from different portions of the body and data is transmitted to a received connected to a nearby PC. The software displays and stores the data and some analysis features are included. An export utility is also included for easy export for custom analysis applications using programs such as LabView, Matlab or Excel.

CleveMed has announced the promotion of Joseph P. Giuffrida, PhD to Vice President, General Manager of the Division of Movement Disorders. CleveMed is continually expanding as a medical device company and Dr. Giuffrida will continue to fill a crucial role to assist with the company’s success.

Dr. Giuffrida, 33, completed his BS, MS and PhD in Biomedical Engineering at Case Western Reserve University with a concentration in rehabilitation engineering. He began his career at CleveMed in 2000 as an Applications Engineer and upon receipt of his PhD in 2004, became a Principal Investigator and eventually Director of the Division of Movement Disorders. Within these roles, Dr. Giuffrida has secured over $10 million in funding from both the National Institutes of Health and the State of Ohio to fuel the research, development, and commercialization of innovative medical devices focused on aiding in the diagnosis and therapy of movement disorders. He has secured FDA clearance to market for a number of CleveMed systems, managed reimbursement strategies for new and emerging technology, established multiple world renowned key opinion leaders and clinical consultants, and lead the marketing and sales teams for CleveMed’s clinical movement disorder products as well as the research and education product lines.

Most notably, CleveMed’s Division of Movement Disorders commercialized and launched Kinesia under Dr. Giuffrida’s direction. This technology is intended to provide a standardized platform for objectively quantifying motor symptoms associated with Parkinson’s disease. Additional research and development in this Division is focused on extending the market applications for Kinesia from clinical office visits to home monitoring and deep brain stimulation programming, assistive technologies to aid in communication for persons with limited mobility and speech impairment and the development of rehabilitation systems to aid in motor recovery after brain injuries such as stroke or cerebral palsy.

In addition to the Division of Movement Disorders, Dr. Giuffrida also manages CleveMed’s line of products focused on the research and education market. Dr. Giuffrida was able to commercialize CleveMed’s wireless physiological monitoring technology into specific academic and university based target applications to increase CleveMed’s sales both domestically and internationally.

At the end of the week, CleveMed will be releasing a new version of the KinetiSense Biokinetic Analysis System.

KinetiSense was originally released in 2007 and was made up of two parts: the Command Module and the Motion Sensor. The Motion Sensor housed 3 accelerometers and 3 gyroscopes that allowed the user to measure linear acceleration and angular velocity about the X, Y and Z axes. The Motion Sensor connected to the Command Module which contained a radio for wireless data transmission, a memory card, battery and EMG amplifiers.

The new KinetiSense system has all of the capabilities of the previous version with the addition of completely new software and the ability to connect up to 5 Motion Sensors to 1 Command Module. This provides the user with much greater flexibility and makes the system appropriate for numerous research applications. Multiple Motion Sensors can be placed on different areas of the body and the data from each is synchronized and displayed within the software.

The KinetiSense software features a new streamlined, user friendly application that allows the user to collect, save and manage data, as well as review and analyze. Data can be exported to third party packages for custom analysis. Also included is the CleveMed Software Development Kit, or SDK. This provides the ability to create custom front end software using the KinetiSense hardware, broadening the application possibilities.

CleveMed is pleased to announce a new partnership with Emona Instruments as the Australian and New Zealand distributor of the CleveLabs laboratory course system.

Emona Instruments was established in 1979 as an importer and distributor of electronic test equipment. Their current product catalog includes electronic and electrical test and measuring instruments and engineering teaching equipment which makes them the ideal distributor for our biomedical engineering teaching equipment. Emona Instruments is established as one of Australia’s leading instrumentation and teaching equipment suppliers to industry, education, defense and government customers.

With the growth of biomedical engineering and biomedical engineering subjects in electrical and mechanical engineering, there is a real need for biomedical teaching and research equipment that meets the specific needs of engineering teaching departments.

CleveLabs is a laboratory course system that uses wireless state of the art physiological monitoring equipment with interactive software to teach engineering, physiology and clinical applications. Expanding the market to Australia and New Zealand opens up many new avenues for CleveMed and Emona Instruments.

For more information on CleveMed, please visit www.CleveMed.com. For more information on Emona Instruments, please visit www.emona.com.au